A mother who believed her enlarged abdomen was a result of constipation received a devastating diagnosis of a rare, incurable cancer. Chelsea Gallimore, aged 33, was urgently hospitalized following excruciating pain and immobility for six hours. Initially attributing her symptoms of abdominal pain, night sweats, and fatigue to constipation, scans unveiled an eight-centimeter mass on her bowel, confirming a gastrointestinal stromal tumor (GIST), a condition affecting around 900 individuals annually in the UK.
Despite typically afflicting individuals aged 55 to 65, Chelsea’s diagnosis at 31 was atypical. Reflecting on her experience, she described waking up with severe stomach swelling and unexplained pain. Subsequent medical tests revealed the tumor, leaving Chelsea in disbelief and emotional numbness. She admitted to dismissing her symptoms as mere constipation, delaying seeking medical attention due to concerns of appearing dramatic.
Undergoing surgery in March 2024, Chelsea commenced treatment with imatinib, a targeted therapy to impede cancer cell growth. Following a pause in medication in June 2025, a recurrence was detected after emergency scans on New Year’s Eve. Subsequent assessments showed significant cancer progression, rendering the disease incurable and inoperable. Chelsea now receives palliative care to manage pain and prolong her life, although the treatment’s efficacy duration remains uncertain.
Expressing the profound impact on her family, Chelsea, a mother to 11-year-old Milo, shared her emotional journey with cancer. Enduring regular scans every three months to monitor treatment effectiveness, she emphasized the ongoing uncertainty surrounding her condition. Planning a November wedding with partner Andrew Mason, Chelsea seeks to cherish moments with loved ones amidst her health challenges.
Advocating for GIST awareness, Chelsea highlights the importance of prompt medical consultation for unusual symptoms. With GIST often symptomless in early stages, delayed diagnoses are common, manifesting as abdominal discomfort, fullness, nausea, and fatigue. Chelsea’s story, shared to raise awareness, contributed to parliamentary discussions leading to the enactment of the Rare Cancers Act.
By sharing her journey on social media, Chelsea aims to educate others about GIST and the significance of symptom vigilance, particularly for those experiencing persistent constipation. Chelsea’s advocacy underscores the need for heightened awareness and understanding of rare cancers, emphasizing the importance of early detection and proactive healthcare practices.
